Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GS.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GS.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GS.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GS.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.258.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.258.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
B.1.258.17ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.258.17ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
B.1.258.17EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.258.17EHuang-EGCAGCAGTACGCACACAATC20552637626357R-1211.7China
B.1.258.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BA.1.21.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.21.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.21.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.1.21.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.1.21.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.1.21.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.21.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.21.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.37EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.1.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.37ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.1.37ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.1.37EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.1.37EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.1.37ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.37ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.36EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.36EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.36ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.36ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.36EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.36EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.36ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HZ.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HZ.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HZ.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HZ.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HZ.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HZ.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HZ.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.30EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.30EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.30ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.30ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.30EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.30EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used